Enclave Capital
Finance · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
880 3rd Ave Fl 12, New York City, New Yo...Phone Number
(646) 454-8600Website
www.enclavecapital.comRevenue
$9.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
1
2
About Enclave Capital
Founded in 1995, Enclave Capital LLC operates as an investment banking firm. The Company offers private placements, PIPE transactions, and registered direct offerings advisory services. Enclave Capital is located in New York, New York.Explore more
Enclave Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enclave Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Enclave Capital is spiking on competitors!
Product Launch: Get notified when Enclave Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Enclave Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at Enclave Capital
Earning: See what the market has to say on Enclave Capital recently announced quarterly report
Enclave Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Enclave Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Enclave Capital had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Enclave Capital
Find more new buyers
Compare Similar Companies to Enclave Capital
Compare insights from companies similar to Enclave Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$10.1M
11-50
Private
<$5M
2006
PI
Phillip IppolitoManaging Director - Chief Financial Officer and Director of Operations
Company Profile Activity
Activity Insights
Enclave Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Enclave Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Enclave Capital.
Enclave Capital financials insights
Gather financial insights about Enclave Capital, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$22K
Enclave Capital Tech Stack
A closer look at the technologies used by Enclave Capital
Most Recent Scoops
Project
, according to a mid-level source in accounting, is in the midst of initiatives related to technical accounting.
Accounting, Financial Reporting, Finance
Project
, according to a mid-level source in accounting, is in the midst of initiatives related to billing and invoicing.
Accounting, Billing & Invoice, Financial Reporting, Finance
Project
, according to a mid-level source in accounting, is in the midst of initiatives related to bill presentment.
Accounting, Billing & Invoice, Financial Reporting, Finance
Project
, according to a mid-level source in accounting, is in the midst of initiatives related to tax compliance. The organization is currently evaluating Canopy.
Accounting, Compliance, Financial Reporting, Finance, Tax
Project
Accounting, Audit, Financial Reporting, Internal Audit & Control, Finance
Enclave Capital News & Media
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™
VANCOUVER, British Columbia--(BUSINESS WIRE)--Lobe Sciences Ltd ("Lobe" or the "Company") (CSE: LOBE), (OTCQB: LOBEF), a biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce the appointment of Enclave Capital and Peak Asset Management (the “Bankers”) to begin the process of raising funds to advance the development of the Company’s patented innovative pharmaceutical candidate, Conjugated Psilocin™. Lobe previously
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enclave Capital
Sign Up For FreeTo access detailed company insights
Founded in 1995, Enclave Capital LLC operates as an investment banking firm. The Company offers private placements, PIPE transactions, and registered direct offerings advisory services. Enclave Capital is located in New York, New York.... Read More
